Equity strategies

Carmignac Portfolio Human Xperience

Luxembourg SICAV sub-fundThematicArticle 9
Share Class

LU2295992163

A thematic Fund focused on customer and employee experience
  • Social thematic Fund : a thematic strategy that focuses both on customer and employee satisfaction.
  • Leveraging the power of social data : quantitative expertise and experience in using ‘alternative’ sources of data.
  • Material upside potential : research performed on all factors to backtest investability and alpha potential.
Asset Allocation
Equities95.3 %
Other4.7 %
Data as of:  Apr 30, 2026.
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
+ 46.0 %
-
+ 42.5 %
+ 37.4 %
+ 13.7 %
From 31/03/2021
To 04/06/2026
Calendar Year Performance 2025
-
-
-
-
-
+ 19.2 %
- 21.8 %
+ 22.6 %
+ 17.6 %
- 0.8 %
Net Asset Value
€145.98
Asset Under Management
28 M €
Net Equity Exposure30/04/2026
95.3%
SFDR - Fund Classification

Article

9
Data as of:  Jun 4, 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. The SFDR classification of the Funds may change over time.

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Manager.
Fund Management Team
[Management Team] [Author] Ejikeme Obe

Obe EJIKEME

Fund Manager, Analyst
The social theme is one of the most disregarded areas within ESG. Yet we believe that companies providing positive experiences to both their customers and employees are better positioned to achieve superior returns over the long run.
[Management Team] [Author] Ejikeme Obe

Obe EJIKEME

Fund Manager, Analyst
View Fund's characteristics

Carmignac Portfolio Human Xperience fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  May 29, 2026.
Fund management team
[Management Team] [Author] Ejikeme Obe

Obe EJIKEME

Fund Manager, Analyst

Market environment

  • May was marked by renewed inflationary pressure, a more hawkish central-bank backdrop and signs of geopolitical de-escalation. In particular, a credible attempt to reach an agreement between the US and Iran emerged towards month-end, helping oil prices decline sharply and fall below USD 100.
  • Equity-market sentiment remained constructive. Investors continued to look through inflation and monetary-policy concerns, supported by hopes of geopolitical easing and strong earnings momentum in AI-related infrastructure.
  • Global equities reached new highs in May, initially led by a narrow group of US technology, semiconductor and AI beneficiaries. Later in the month, expectations of a US-Iran agreement triggered a rebound in previous laggards and “war losers”, allowing European equities to partially catch up.
  • Emerging markets outperformed developed markets, led by Korea and Taiwan, which benefited from their exposure to the AI supply chain and continued hyperscaler capex demand.
  • US market leadership remained highly concentrated, with technology and especially semiconductors standing out, while broader market participation stayed weak.

Performance commentary

  • Over the month of May, the fund had a positive absolute performance and outperformed its index, primarily driven by its overweight to Technology and stock selection in the sector.
  • Within these names, Lenovo was the big standout over the month after they reported revenues up 27% year over year, demonstrating the highest growth in 5 years.
  • The re-rating demonstrated how investors reclassified it from a PC manufacturer into a genuine AI infrastructure and devices compounder.
  • Other tech names that benefitted from this rally were mostly linked to the AI infrastructure theme, with names like Cisco, Samsung, TSMC and Nvidia continuing its market dominance.
  • Our stock selection in healthcare was also strong thanks to Eli Lilly showing its best month since the start of the year following earnings beat driven by revenues deriving from their GLP-1 drugs as well as positive Phase 1b and phase 3 results for new drugs in their pipeline.

Outlook strategy

  • We did a few changes to the portfolio over the month of May. We took profits and reduced our exposure to some of our technology names that showed had performed well recently and added on weakness in names like BBVA, L’Oreal and Eli Lilly.
  • We remain cautious in positioning our portfolio and continue to focus on higher quality companies.

Performance Overview

Data as of:  Jun 4, 2026.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The Fund presents a risk of loss of capital.
Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
​From 01/01/2013 the equity index reference indicators are calculated net dividends reinvested.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 05/06/2026

Carmignac Portfolio Human Xperience Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  Apr 30, 2026.
North America61.6%
Europe20.6%
Asia14.3%
Asia-Pacific3.5%
View details

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  Apr 30, 2026.
Equity Investment Weight95.3%
Net Equity Exposure95.3%
Number of Equity Issuers36
Active Share74.5%

Articles that may interest you

Notice to shareholdersMay 8, 2026English

Merger of “Human Xperience” into “Investissement” in Carmignac Portfolio

2 minute(s) read
Find out more
Our viewsFebruary 23, 2026English

Healthy minds, healthy markets: The financial case for happy employees

5 minute(s) read
Find out more
Strategies insightsOctober 23, 2025English

Carmignac Portfolio Human Xperience: Letter from the Fund Manager - Q3 2025

5 minute(s) read
Find out more
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.